Posted by Michael Wonder on 15 Jun 2022
NICE’s early value assessment for medtech: panning for nuggets of innovation gold
15 June 2022 - The explosion in digital health products has left NHS commissioners wondering how they can possibly sift out what works and what provides maximum benefit for the service and for patients.
NICE’s Early Value Assessment for Medtech will help do just that. By offering a rapid assessment of digital products, devices and diagnostics for clinical effectiveness and value for money, the service and patients will be able to benefit sooner.
